Physician

Rambabu Tummala, MD

According to 2025 Medicare claims, Rambabu Tummala, MD (NPI: 1295716645) practices hematology/oncology in the Orlando-Kissimmee-Sanford, FL market, with the plurality of this provider's patient population coming from Lake, FL. This provider's primary affiliated billing organization is FLORIDA CANCER SPECIALISTS & RESEARCH INSTITUTE, LLC (NPI: 1760590962; TIN: 65-0825133) and primary practice location at 32778-5270.

Tummala's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,004 traditional Medicare patients, billed 222,627 HCPCS/CPT codes, and received $3,494,460 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 842 prescription claims across 225 beneficiaries totaling $2,608,684 in drug costs, led by Revlimid (Lenalidomide). 2020 DME data shows 49 claims. Open Payments data shows 91 records totaling $2,144. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $1,230,068 to $2,608,684. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.1M$4.1M2015 Medicare payment: $1,744,794 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,849,902 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $3,153,863 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $4,120,379 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $4,042,389 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,627,578 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,792,129 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,706,974 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,714,687 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,494,460 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,126240,710$1,744,794
20161,402359,866$2,849,902
20171,423338,575$3,153,863
20181,329347,886$4,120,379
20191,452342,772$4,042,389
20201,182231,340$3,627,578
20211,109186,229$3,792,129
20221,043266,380$3,706,974
20231,018250,592$3,714,687
20241,004222,627$3,494,460

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.5M$3.0M2015 Drug cost: $1,230,068 (USD; Tot_Drug_Cst)2016 Drug cost: $1,886,053 (USD; Tot_Drug_Cst)2017 Drug cost: $1,818,898 (USD; Tot_Drug_Cst)2018 Drug cost: $2,156,262 (USD; Tot_Drug_Cst)2019 Drug cost: $2,473,084 (USD; Tot_Drug_Cst)2020 Drug cost: $2,663,724 (USD; Tot_Drug_Cst)2021 Drug cost: $3,038,971 (USD; Tot_Drug_Cst)2022 Drug cost: $2,337,874 (USD; Tot_Drug_Cst)2023 Drug cost: $3,018,426 (USD; Tot_Drug_Cst)2024 Drug cost: $2,608,684 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152351,051$1,230,068
20162671,312$1,886,053
20172771,296$1,818,898
20182751,160$2,156,262
20192821,159$2,473,084
20202981,377$2,663,724
20212671,147$3,038,971
2022232846$2,337,874
2023245900$3,018,426
2024225842$2,608,684

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$5.9K$12K2015 Medicare payment: $11,796 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $7,975 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $9,533 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $5,398 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $3,056 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
201552286$11,796
201625180$7,975
2017N/R16$9,533
2018N/RN/RN/R
2019N/R38$5,398
2020N/R49$3,056
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more236613$97
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more6801,407$63
96372Injection of drug or substance under skin or into muscle190827$10
36415Insertion of needle into vein for collection of blood sample6872,428$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count6372,469$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RevlimidLenalidomide441,232$803,900
CalquenceAcalabrutinib Maleate20600$307,393
XtandiEnzalutamide21630$296,164
ImbruvicaIbrutinib22640$213,323
JakafiRuxolitinib Phosphate12360$207,555

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.91$2,144Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Rambabu Tummala, MD?

Tedicare shows public-source Medicare data for Rambabu Tummala, MD (NPI 1295716645), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rambabu Tummala, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Rambabu Tummala, MD?

Rambabu Tummala, MD is linked to FLORIDA CANCER SPECIALISTS & RESEARCH INSTITUTE, LLC (billing NPI 1760590962) in the available physician profile data.

Does Rambabu Tummala, MD have Open Payments data?

Rambabu Tummala, MD has 91 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.